A Delluc, E Pasquier, L de Saint Martin, and D Mottier. 2006. “Rituximab’s Cost for the Treatment of Primary Cold Agglutinin Disease Should Not Limit Its Use”. Haematologica 91 (3). Pavia, Italy, ECR05-ECR05. https://doi.org/10.3324/%x.